Dendritic Cells
Dendritic cells are specialized immune cells that play a crucial role in the recognition and processing of foreign antigens in the body. They are found mainly in the lymphoid tissues and are responsible for activating and regulating the immune response against pathogens, tumor cells, and other abnormal cellular components. In addition to their immune functions, dendritic cells are also being investigated for their potential therapeutic applications in neurological disorders. Recent studies have shown that dendritic cell therapy can improve the symptoms of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and autism spectrum disorder. There are two main approaches to using dendritic cell therapy in neurological disorders. The first approach involves the use of ex vivo generated dendritic cells that are loaded with antigens derived from the patient's own cells or from the targeted disease-causing agents. These dendritic cells are then reintroduced into the patient's body to stimulate an immune response against the specific antigens. The second approach involves the use of genetically modified dendritic cells that express or secrete therapeutic molecules, such as neurotrophic factors, anti-inflammatory cytokines, and growth factors. These modified dendritic cells can be directly injected into the brain or administered systemically, where they can migrate to the damaged or diseased nervous tissue and promote its regeneration and repair. Overall, dendritic cell therapy holds great promise for the treatment of various neurological disorders, and ongoing research is expected to provide further insights into its mechanisms and therapeutic potential.
← Journal of Neurological Research And Therapy